Dispensing of generically equivalent drug product or interchangeable biological product

Checkout our iOS App for a better way to browser and research.

(a)(1) When a pharmacist receives a prescription for a brand name drug, the pharmacist may dispense a generically equivalent drug product or interchangeable biological product that is listed in the Orange Book; provided, that the pharmacist shall dispense a generically equivalent drug product or interchangeable biological product if requested by the purchaser, except as provided in § 48-803.03.

(2) If a generic substitution is made pursuant to this subsection, the pharmacist shall dispense the generically equivalent drug product or interchangeable biological product in stock having the lowest cost to the person purchasing the drug product.

(b) When a pharmacist receives a prescription for a drug by generic name or interchangeable biological product, the pharmacist shall dispense the listed product in stock that has the lowest cost to the person purchasing the drug product.

(c) Repealed.

(Sept. 10, 1976, D.C. Law 1-81, title III, § 302, 23 DCR 2460; Apr. 7, 1977, D.C. Law 1-114, § 4(a), 23 DCR 8743; Mar. 11, 2010, D.C. Law 18-118, § 2(b), 57 DCR 901; Oct. 20, 2020, D.C. Law 23-133, § 2(c), 67 DCR 9880.)

Prior Codifications

1981 Ed., § 33-732.

1973 Ed., § 33-832.

Section References

This section is referenced in § 48-803.03 and § 48-803.05.

Effect of Amendments

D.C. Law 18-118 rewrote the section.


Download our app to see the most-to-date content.